Shopping Cart
- Remove All
- Your shopping cart is currently empty
SYNTi, a PDZ domain inhibitor, specifically targets the syndecan/syntenin protein-protein interaction, demonstrating an IC50 of 400 nM and a ligand efficiency (LE) value of 0.24. It holds potential for use in breast cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | SYNTi, a PDZ domain inhibitor, specifically targets the syndecan/syntenin protein-protein interaction, demonstrating an IC50 of 400 nM and a ligand efficiency (LE) value of 0.24. It holds potential for use in breast cancer research. |
Molecular Weight | 567.4 |
Formula | C28H24BrFN2O5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.